CN103800746A - Traditional Chinese medicine composition for treating acute pelvic inflammation - Google Patents
Traditional Chinese medicine composition for treating acute pelvic inflammation Download PDFInfo
- Publication number
- CN103800746A CN103800746A CN201410099826.8A CN201410099826A CN103800746A CN 103800746 A CN103800746 A CN 103800746A CN 201410099826 A CN201410099826 A CN 201410099826A CN 103800746 A CN103800746 A CN 103800746A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- inflammatory disease
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 39
- 230000001154 acute Effects 0.000 title claims abstract description 29
- 201000006518 pelvic inflammatory disease Diseases 0.000 title claims abstract description 27
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 241000218176 Corydalis Species 0.000 claims abstract description 8
- 239000004863 Frankincense Substances 0.000 claims abstract description 3
- 241000555682 Forsythia x intermedia Species 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims description 15
- 210000000582 Semen Anatomy 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 14
- 241000717739 Boswellia sacra Species 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 7
- 241001057584 Myrrha Species 0.000 claims description 7
- 241000245240 Lonicera Species 0.000 claims description 5
- 240000001972 Gardenia jasminoides Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 7
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 240000009301 Coix lacryma-jobi Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 240000005389 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 241000736199 Paeonia Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 240000005001 Paeonia suffruticosa Species 0.000 abstract 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract 1
- 240000000805 Patrinia villosa Species 0.000 abstract 1
- 235000019109 Patrinia villosa Nutrition 0.000 abstract 1
- 241000972673 Phellodendron amurense Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 235000014063 licorice root Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000009910 sargent gloryvine Substances 0.000 abstract 1
- 241000555712 Forsythia Species 0.000 description 4
- 241000157835 Gardenia Species 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 210000003679 Cervix Uteri Anatomy 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000001737 promoting Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 231100000486 side effect Toxicity 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000001015 Abdomen Anatomy 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 210000004369 Blood Anatomy 0.000 description 1
- 210000002808 Connective Tissue Anatomy 0.000 description 1
- 210000003608 Feces Anatomy 0.000 description 1
- 210000004392 Genitalia Anatomy 0.000 description 1
- 206010019233 Headache Diseases 0.000 description 1
- 210000001624 Hip Anatomy 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000000509 Infertility Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010025482 Malaise Diseases 0.000 description 1
- 210000003101 Oviducts Anatomy 0.000 description 1
- 210000004303 Peritoneum Anatomy 0.000 description 1
- 229940023488 Pill Drugs 0.000 description 1
- 231100000614 Poison Toxicity 0.000 description 1
- 210000004915 Pus Anatomy 0.000 description 1
- 210000004291 Uterus Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000001684 chronic Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000002522 swelling Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Abstract
The invention relates to a traditional Chinese medicine composition for treating acute pelvic inflammation. The traditional Chinese medicine composition is prepared from the following raw pharmaceutical materials in parts by weight: 27-33 parts of forsythia fruit, 27-33 parts of honeysuckle flower, 27-33 parts of sargentgloryvine, 27-33 parts of whiteflower patrinia herb, 27-33 parts of phellodendron bark, 27-33 parts of hedyotis diffusa, 15-21 parts of dipsacus root, 8-12 parts of coix seed, 8-12 parts of gardenia, 8-12 parts of peach kernel, 8-12 parts of coptis root, 8-12 parts of tree peony bark, 8-12 parts of corydalis tuber, 8-12 parts of toosendan fruit, 3-7 parts of red peony root, 3-7 parts of frankincense and 3-7 parts of myrrh and 3-7 parts of licorice root. The traditional Chinese medicine composition has the advantages of stable treatment effect and no side effects.
Description
Technical field
The present invention relates to technical field of Chinese medicines, particularly relate to a kind of Chinese medicine composition for the treatment of acute pelvic inflammatory disease.
Background technology
Pelvic inflammatory disease refers to the inflammation that female pelvic cavity genitals and connective tissue around thereof, pelvic peritoneum occur, and is divided into acute and acute two kinds.Clinical research shows, hypogastric region constant pain and leucorrhoea grow in quantity are its cardinal symptom.At pelvic inflammatory disease acute attack stage often with symptoms such as generating heat, have a headache, be afraid of cold, and chronic pelvic inflammatory disease between period of disease often with the soreness of waist, abdominal pain in menstruation, through the symptom such as measuring too much, if treatment not in time can be shone into secondary infertility because of atresia of uterine tube.In recent years, its sickness rate is more and more higher, has become common gynecological disease, has had a strong impact on numerous women's physical and mental health, brings inconvenience to work, life.
At present, the medicine for the treatment of acute pelvic inflammatory disease is more, but has the deficiencies such as curative effect is unstable, side effect is large.
Summary of the invention
The technical problem to be solved in the present invention is: for solving the deficiencies in the prior art, the invention provides a kind of Chinese medicine composition for the treatment of acute pelvic inflammatory disease, the present invention has advantages of stable curative effect, has no side effect.
Treat a Chinese medicine composition for acute pelvic inflammatory disease, made by the crude drug of following weight portion: Fructus Forsythiae 27-33 part, Flos Lonicerae 27-33 part, Caulis Sargentodoxae 27-33 part, Herba Patriniae 27-33 part, Cortex Phellodendri 27-33 part, Herba Hedyotidis Diffusae 27-33 part, Radix Dipsaci 15-21 part, Semen Coicis 8-12 part, Fructus Gardeniae 8-12 part, Semen Persicae 8-12 part, Rhizoma Coptidis 8-12 part, Cortex Moutan 8-12 part, Rhizoma Corydalis 8-12 part, Fructus Toosendan 8-12 part, Radix Paeoniae Rubra 3-7 part, Olibanum 3-7 part, Myrrha 3-7 part, Radix Glycyrrhizae 3-7 part.
The Chinese medicine composition of described treatment acute pelvic inflammatory disease, it is preferably made up of the crude drug of following weight portion: 30 parts of Fructus Forsythiaes, 30 parts of Flos Loniceraes, 30 parts of Caulis Sargentodoxae, 30 parts of Herba Patriniae, 30 parts of Cortex Phellodendris, 30 parts of Herba Hedyotidis Diffusaes, 18 parts of Radix Dipsacis, 10 parts of Semen Coiciss, 10 parts of Fructus Gardeniaes, 10 parts, Semen Persicae, 10 parts of Rhizoma Coptidis, 10 parts of Cortex Moutans, 10 parts of Rhizoma Corydalis, 10 parts of Fructus Toosendans, 5 parts of Radix Paeoniae Rubra, 5 parts of Olibanums, 5 parts of Myrrhas, 5 parts, Radix Glycyrrhizae.
The preparation method of the Chinese medicine composition of described treatment acute pelvic inflammatory disease is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
The application of the Chinese medicine composition of described treatment acute pelvic inflammatory disease in preparation treatment acute pelvic inflammatory disease medicine.
The beneficial effect that the present invention compared with prior art had is: the present invention is under Traditional Chinese medical theory and clinical experience guidance, chooses each crude drug and proportioning thereof, has the function of removing toxic substances and promoting subsidence of swelling, promoting blood circulation and cooling blood, realizes the object for the treatment of acute pelvic inflammatory disease.
Below in conjunction with clinical experiment, beneficial effect of the present invention is described:
(1) clinical data: the present invention treats acute pelvic inflammatory disease patient 63 examples altogether, the age is 21-38 year.
(2) Therapeutic Method: the oral drugs that Chinese medicine composition of the present invention is made can be decoction, tablet, pill and capsule etc., take decoction as example, 1 pair of every day, point takes for 2 times, early, respectively take 1 evening, within 7 days, is 1 course for the treatment of.
(3) the standard of curative effect evaluation:
Cure: clinical symptoms disappears completely;
Take a turn for the better: clinical symptoms is obviously improved;
Do not heal: clinical primary symptom shape does not improve.
(4) therapeutic outcome: the present invention treats acute pelvic inflammatory disease patient 63 examples altogether, through 1-3 course of therapy, cures 54 examples, accounts for 85.7%, and 8 examples that take a turn for the better, account for 12.7%, and 1 example that do not heal, accounts for 1.6%, and effective percentage is 98.4%, has no any side effect; Cure in 54 examples, cure 18 examples 1 course for the treatment of, cure 20 examples 2 courses for the treatment of, cure 16 examples 3 courses for the treatment of, follows up a case by regular visits to half by 1 year after healing, is showed no recurrence; Result shows, the present invention has advantages of stable curative effect, has no side effect.
(5) model case:
1, field so-and-so, 24 years old, hypogastralgia 6 days, watery stool 2 days.39 ℃ of body temperature, face of acute ill, moans ceaselessly, and expression is painful, sits up straight position, hypogastric region tenderness, rebound tenderness.Gynecologial examination: palace mouth has purulent secretion, cervix uteri hyperemia, retroposition of uterus is often large, and posterior fornix is full.Canescence pus is extracted in culdocentesis out, is diagnosed as acute pelvic inflammatory disease; Taking Chinese medicine preparation of the present invention cures 3 courses for the treatment of.
2, sternly certain, 35 years old, lower abdomen pain 7 days, 38.5 ℃ of body temperature, face of acute ill, hypogastric region pendant rises.Gynecologial examination: cervix uteri purulent secretion, lifting pain, palace body tenderness is obvious, is diagnosed as acute pelvic inflammatory disease; Taking Chinese medicine preparation of the present invention cures 1 course for the treatment of.
The specific embodiment
Embodiment 1:
Treat a Chinese medicine composition for acute pelvic inflammatory disease, made by the crude drug of following weight portion: 27 parts of Fructus Forsythiaes, 27 parts of Flos Loniceraes, 27 parts of Caulis Sargentodoxae, 27 parts of Herba Patriniae, 27 parts of Cortex Phellodendris, 27 parts of Herba Hedyotidis Diffusaes, 15 parts of Radix Dipsaci, 8 parts of Semen Coiciss, 8 parts of Fructus Gardeniaes, 8 parts, Semen Persicae, 8 parts of Rhizoma Coptidis, 8 parts of Cortex Moutans, 8 parts of Rhizoma Corydalis, 8 parts of Fructus Toosendans, 3 parts of Radix Paeoniae Rubra, 3 parts of Olibanums, 3 parts of Myrrhas, 3 parts, Radix Glycyrrhizae.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Embodiment 2:
Treat a Chinese medicine composition for acute pelvic inflammatory disease, made by the crude drug of following weight portion: 30 parts of Fructus Forsythiaes, 30 parts of Flos Loniceraes, 30 parts of Caulis Sargentodoxae, 30 parts of Herba Patriniae, 30 parts of Cortex Phellodendris, 30 parts of Herba Hedyotidis Diffusaes, 18 parts of Radix Dipsacis, 10 parts of Semen Coiciss, 10 parts of Fructus Gardeniaes, 10 parts, Semen Persicae, 10 parts of Rhizoma Coptidis, 10 parts of Cortex Moutans, 10 parts of Rhizoma Corydalis, 10 parts of Fructus Toosendans, 5 parts of Radix Paeoniae Rubra, 5 parts of Olibanums, 5 parts of Myrrhas, 5 parts, Radix Glycyrrhizae.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Embodiment 3:
Treat a Chinese medicine composition for acute pelvic inflammatory disease, made by the crude drug of following weight portion: 33 parts of Fructus Forsythiaes, 33 parts of Flos Loniceraes, 33 parts of Caulis Sargentodoxae, 33 parts of Herba Patriniae, 33 parts of Cortex Phellodendris, 33 parts of Herba Hedyotidis Diffusaes, 21 parts of Radix Dipsaci, 12 parts of Semen Coiciss, 12 parts of Fructus Gardeniaes, 12 parts, Semen Persicae, 12 parts of Rhizoma Coptidis, 12 parts of Cortex Moutans, 12 parts of Rhizoma Corydalis, 12 parts of Fructus Toosendans, 7 parts of Radix Paeoniae Rubra, 7 parts of Olibanums, 7 parts of Myrrhas, 7 parts, Radix Glycyrrhizae.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Claims (4)
1. a Chinese medicine composition for the treatment of acute pelvic inflammatory disease, is characterized in that: the crude drug by following weight portion is made: Fructus Forsythiae 27-33 part, Flos Lonicerae 27-33 part, Caulis Sargentodoxae 27-33 part, Herba Patriniae 27-33 part, Cortex Phellodendri 27-33 part, Herba Hedyotidis Diffusae 27-33 part, Radix Dipsaci 15-21 part, Semen Coicis 8-12 part, Fructus Gardeniae 8-12 part, Semen Persicae 8-12 part, Rhizoma Coptidis 8-12 part, Cortex Moutan 8-12 part, Rhizoma Corydalis 8-12 part, Fructus Toosendan 8-12 part, Radix Paeoniae Rubra 3-7 part, Olibanum 3-7 part, Myrrha 3-7 part, Radix Glycyrrhizae 3-7 part.
2. the Chinese medicine composition for the treatment of acute pelvic inflammatory disease according to claim 1, is characterized in that: the crude drug by following weight portion is made: 30 parts of Fructus Forsythiaes, 30 parts of Flos Loniceraes, 30 parts of Caulis Sargentodoxae, 30 parts of Herba Patriniae, 30 parts of Cortex Phellodendris, 30 parts of Herba Hedyotidis Diffusaes, 18 parts of Radix Dipsacis, 10 parts of Semen Coiciss, 10 parts of Fructus Gardeniaes, 10 parts, Semen Persicae, 10 parts of Rhizoma Coptidis, 10 parts of Cortex Moutans, 10 parts of Rhizoma Corydalis, 10 parts of Fructus Toosendans, 5 parts of Radix Paeoniae Rubra, 5 parts of Olibanums, 5 parts of Myrrhas, 5 parts, Radix Glycyrrhizae.
3. the preparation method of the Chinese medicine composition for the treatment of acute pelvic inflammatory disease according to claim 1 and 2, is characterized in that: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
4. the application of the Chinese medicine composition for the treatment of acute pelvic inflammatory disease according to claim 1 and 2 in preparation treatment acute pelvic inflammatory disease medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410099826.8A CN103800746A (en) | 2014-03-18 | 2014-03-18 | Traditional Chinese medicine composition for treating acute pelvic inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410099826.8A CN103800746A (en) | 2014-03-18 | 2014-03-18 | Traditional Chinese medicine composition for treating acute pelvic inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103800746A true CN103800746A (en) | 2014-05-21 |
Family
ID=50698441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410099826.8A Pending CN103800746A (en) | 2014-03-18 | 2014-03-18 | Traditional Chinese medicine composition for treating acute pelvic inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103800746A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104436029A (en) * | 2014-11-13 | 2015-03-25 | 廖福存 | Drug for treating pelvic inflammatory disease |
| CN105288506A (en) * | 2015-12-03 | 2016-02-03 | 苏州枫灵医药科技有限公司 | Pharmaceutical preparation for treating acute pelvic inflammatory disease |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101085271A (en) * | 2007-06-29 | 2007-12-12 | 李永红 | Oral administration traditional Chinese medicine composition for curing chronic pelvic inflammatory disease |
| CN101129868A (en) * | 2007-09-03 | 2008-02-27 | 孙元萍 | Orally taken traditional Chinese medicine composition for treating chronic pelvic inflammatory disease |
-
2014
- 2014-03-18 CN CN201410099826.8A patent/CN103800746A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101085271A (en) * | 2007-06-29 | 2007-12-12 | 李永红 | Oral administration traditional Chinese medicine composition for curing chronic pelvic inflammatory disease |
| CN101129868A (en) * | 2007-09-03 | 2008-02-27 | 孙元萍 | Orally taken traditional Chinese medicine composition for treating chronic pelvic inflammatory disease |
Non-Patent Citations (1)
| Title |
|---|
| 毛宗群: "浅谈中医治疗急慢性盆腔炎的经验", 《中国社区医师》, vol. 10, no. 197, 31 December 2008 (2008-12-31), pages 77 - 78 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104436029A (en) * | 2014-11-13 | 2015-03-25 | 廖福存 | Drug for treating pelvic inflammatory disease |
| CN105288506A (en) * | 2015-12-03 | 2016-02-03 | 苏州枫灵医药科技有限公司 | Pharmaceutical preparation for treating acute pelvic inflammatory disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103316174B (en) | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof | |
| CN103393913B (en) | Chinese medicinal composition for treating uterine prolapse | |
| CN103142879B (en) | Traditional Chinese medicine for treating rubella | |
| CN103800843B (en) | A kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease | |
| CN104435694A (en) | External traditional Chinese medicine medicated wine for treating rheumatism | |
| CN103830454A (en) | Traditional Chinese medicine composition for treating postpartum urinary retention | |
| CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
| CN104958448A (en) | Medicine for treating puerperal infection | |
| CN101983644A (en) | Medicament for treating sequelae of apoplexy | |
| CN103356969A (en) | Traditional Chinese medicine composition for treating hysteromyoma | |
| CN103784804A (en) | Pharmaceutical composition for treating benign prostatic hyperplasia | |
| CN103800746A (en) | Traditional Chinese medicine composition for treating acute pelvic inflammation | |
| CN103768358B (en) | A kind of Chinese medicine composition for the treatment of chronic prostatitis | |
| CN103341025B (en) | Traditional Chinese medicine composition for treating premature ejaculation | |
| CN103550668B (en) | A kind of Chinese medicine for the treatment of gynecological's habitual abortion disease | |
| CN102475866A (en) | Medicine for preventing abortion and preparation method thereof | |
| CN102205067B (en) | Traditional Chinese medicine composition for treating chronic urticaria | |
| CN104042970A (en) | Traditional Chinese medicine (TCM) composition for allergic purpura | |
| CN103768368A (en) | Traditional Chinese medicine composition for treating acute epididymitis | |
| CN103800664A (en) | Traditional Chinese medicine composition for treating menopausal syndrome | |
| CN103463412A (en) | Traditional Chinese medicinal composition for treating oral ulcer | |
| CN103445905B (en) | Condom capable of treating gynecological inflammations | |
| CN103800761A (en) | Traditional Chinese medicine composition for treating cervicitis | |
| CN106177774A (en) | A kind of medicine treating pelvic inflammatory disease | |
| CN104257898A (en) | Traditional Chinese medicine preparation for treating irregular postpartum menstruation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140521 |